A warm welcome to Cecilia Persson, Head of Global Procurement Indirect & Enabling Functions at AstraZeneca joining CPO Outlook 2022. Cecilia invite you to join her Theme Discussions, round table discussions on October 12th. Her discussions will focus on sustainability from a procurement perspective – much needed experience exchange!
On October 12th and 13th you who join us in Stockholm can choose from a series of small group round table discussions. All focusing on different aspects important for you working in procurement. Finally we are back with that summit where you walk away with a sense of community.
Registration is open and there will be limited seats.
Below what Cecilia will bring up for discussion.
How can procurement develop sustainability collaboration with the business and suppliers?
Almost all companies have high set sustainability targets today. Carbon footprints, science based targets as examples. Scope 3 relate to everything procurement and supply chain do together with suppliers. But procurement is just one part – the business who request the supplies and services and suppliers who are the obvious opposite partner all need to agree, comply and engage in targets set. Easier said than done!
During this session you will share experiences and concrete ways of working engaging the business and suppliers in corporate sustainability work.
Discuss;
- How are you making sure the business is engaged in the targets set and incorporated in contracts?
- In what ways are you engaging with suppliers to follow up on targets set?
- How do you help suppliers comply with targets and be able to share data?
- How much may it cost to ensure set targets given there is not a unified way of sharing data?
Moderator: Cecilia Persson, Head of Global Procurement Indirect & Enabling Functions, AstraZeneca
About AstraZeneca
Our strategy is straightforward.
AstraZeneca website
We are science and innovation-led and have a diversified portfolio of medicines across primary, specialty care and rare diseases.
We are focused on leading in the therapy areas where we believe we can make the most meaningful difference to patients: Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism and Respiratory & Immunology); and Rare Disease.
We have global strength with balanced presence across regions.
We are committed to operating in a way that recognises the interconnection between business growth, the needs of society and the limitations of our planet.
We have three priorities designed to deliver our strategy.
ESG is a reality as are Scope 3 challenges. During CPO Outlook 2022 you can move beyond “let’s come together” – and actually do just that.
About CPO Outlook 2022
EBG love visions and are curious about the future. But – we know you need to find inspiration and concrete solutions to issues you have today. An EBG summit therefor consist of dozens of round table discussions. Informal yet to the point discussions that give you the possibility to take advantage of hundreds of years of know how.
After you leave an EBG summit you can catch up with those you met via EBG | Community. EBG help bring groups of people having met together also after the summit. No more needles in haystacks – we help you stay connected!
You who join us in Stockholm will choose what sessions to join, limited seats at a first come first serve basis.
